Japanese doc testifies about inflating placebo counts in Diovan trial

A Japanese physician testified in a case involving Novartis Pharma K.K. and its Diovan (valsartan) drug for high blood pressure that he falsified a report while participating in clinical trials for marketing approval, sources said. The doctor said he inflated the number of placebo patients in the trial. Report